Please login to the form below

Not currently logged in
Email:
Password:

CHB

This page shows the latest CHB news and features for those working in and with pharma, biotech and healthcare.

GSK’s Ionis-partnered hepatitis B drug hits the mark in phase 2

GSK’s Ionis-partnered hepatitis B drug hits the mark in phase 2

Around 260 million people worldwide are currently living with CHB compared to around 70 million with hepatitis C. ... GSK3228836 uses antisense oligonucleotide technology to suppress the virus and viral proteins to functionally cure CHB.

Latest news

More from news
Approximately 1 fully matching, plus 4 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Spirit, an OPEN Health Company

We find the soul in the science, the humanity in the data, harnessing the power of creativity to deliver medical...

Latest intelligence

What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...